Abstract
We report single institution outcome of brief, intensive ara-C-based chemotherapy using bone marrow transplantation as primary intensification for untreated adult patients with acute lymphoblastic leukemia (ALL). Overall disease-free and overall survival were inferior to those reported with prolonged chemotherapy modeled on pediatric protocols. Survival and disease-free survival were superior for patients receiving allogeneic BMT compared with chemopurged autologous transplant or maintenance chemotherapy (patients ineligible for or declining BMT). In multivariate analysis, non-L2-FAB, higher ara-C dose, absence of CNS disease, non-Ph1+ karyotype, allogeneic BMT, T cell phenotype, and younger age were associated with improved disease-free survival. Autologous BMT was not superior to chemotherapy, and appears unlikely to provide adequate curative treatment for most adult ALL patients if not followed by maintenance.
References
May 1, 1992·Leukemia & Lymphoma·P Ljungman, G Gahrton
Jan 1, 1991·Medical and Pediatric Oncology·R Gonzales-ChambersC S Rosenfeld
May 1, 1991·Transplantation·T FaconF Bauters
Jun 1, 1989·British Journal of Haematology·P BordigoniA Fischer
Jul 17, 1986·The New England Journal of Medicine·A M YeagerW H Burns
Jan 1, 1995·Acta Haematologica·H NakanoM Kobayashi
Jan 1, 1993·Journal of Hematotherapy·C I Civin, S D Gore
Sep 15, 1995·Annals of Internal Medicine·M J ZhangD J Weisdorf
Feb 1, 1995·Annals of Hematology·R WillemzeW E Fibbe
Oct 28, 1993·The New England Journal of Medicine·G K RiveraW M Crist
Sep 1, 1996·Leukemia & Lymphoma·S H KaufmannS D Gore
Oct 27, 1997·Leukemia·L ForoniA V Hoffbrand
Apr 7, 1999·British Journal of Haematology·R BassanT Barbui
Mar 30, 2000·Leukemia Research·P J RosenF R Appelbaum
Feb 26, 2004·International Journal of Hematology·Hiroatsu IidaYoshihisa Morishita
Feb 27, 2007·International Journal of Hematology·Shuichi MizutaYasuo Morishima
Citations
Jan 28, 2009·Annals of Hematology·Michael DoubekJiri Mayer
Sep 21, 2000·Critical Reviews in Oncology/hematology·N SabaA Keating
Apr 15, 2008·Bone Marrow Transplantation·B SirohiJ Mehta
Jun 12, 2003·Current Opinion in Hematology·Partow Kebriaei, Richard A Larson
Nov 21, 2007·Hematology·Hillard M Lazarus, Selina Luger
Jun 9, 2004·Critical Reviews in Oncology/hematology·Renato BassanRoel Willemze
Jan 10, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Theresa HahnPhilip L McCarthy
Jun 3, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Eric DeconinckJean-Michel Boiron
Oct 3, 2008·Cancer Letters·Xiao-shan LiuYing-mu Cai
Jan 22, 2005·Experimental Hematology·Nicole FellerGerrit Jan Schuurhuis
Aug 22, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ivan AksentijevichIan W Flinn
Nov 19, 2009·Biochemical and Biophysical Research Communications·Shogo KojimaKeizo Takenaga
Feb 4, 2009·Leukemia Research·Marco MontilloEnrica Morra
Apr 13, 2004·Bone Marrow Transplantation·J MehtaS Singhal
Jun 5, 2003·Expert Review of Molecular Diagnostics·Beate Gleissner, Eckhard Thiel